November is PAH awareness month. It seems fitting to reflect on my career choice to specialize in the treatment of patients with PAH. … [Read more...]
Archives for November 2014
November 18th is the First Ever CTEPH Awareness Day
As part of PAH Awareness Month this year November 18th has been assigned as the official CTEPH Awareness Day. This will be the first ever awareness day focused on CTEPH or chronic thromboembolic pulmonary hypertension. … [Read more...]
Combination Therapy for PAH: AMBITION Study Yields Impressive Results
Gilead recently presented the results of AMBITION, their largest PAH study. This study compared the long term outcomes of pulmonary arterial hypertension patients who had been recently diagnosed and were randomized to either Tadalafil (Adcirca), Ambrisentan (Letairis) or the combination of the two. … [Read more...]